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ABSTRACT 
Objective:  To examine the outcome of Endoscopic Third Ventriculostomy in 80 consecutive patients operated in 
Irfan General Hospital and Prime Teaching Hospital Peshawar. 
Materials and Methods:  Prospective observational study was conducted in the neurosurgery department of 
Prime Teaching Hospital and Irfan General Hospital Peshawar. 80 patients (48 male and 32 female) were 
followed for 3 months. The inclusion criteria all patients with Third ventricular hydrocephalus were included in 
this study and the exclusion criteria unwilling patients and those who opted for VP shunting rather than ETV. 
Data was analyzed using SPSS version 22. 
Results:  ETV was performed in 80 patients. With highest success rate inAqueductal stenosis and posterior fossa 
tumors 88% and 87% respectively. ETV had a lowest success score of 50% in patients with Hydrocephalus TBM. 
Common post-operative complications were seizures and CSF leakage. 
Conclusion:  ETV is less invasive and effective treatment for non-communicating hydrocephalus.ETV is most 
effective in treating aqueductal stenosis and posterior fossa tumors. The overall success rate of ETV is 74%. 
Based on these findings, it is recommended that ETV should be attempted as first line treatment for patients with 
triventricular hydrocephalus due to various pathologies. 
Keywords:  ETV (Endoscopic Third Ventriculostomy), communicating hydrocephalus, Posterior fossa tumors, 
Aqueductal stenosis. 
 
INTRODUCTION 
Hydrocephalus is one of the commonest neurological 
entity .1 It is the dilatation of ventricular system due to 
the imbalance of cerebrospinal fluid production and 
absorption.2 The common causes of hydrocephalus are 
congenital, infectious, post-traumatic and tumors. 
Congenital hydrocephalus is common due to 
aqueductal stenosis.3 In developing countries 
tuberculous meningitis (TBM) is one of the common 
cause of hydrocephalus.1 The common signs and 
symptoms of hydrocephalus are those of raised 
Intracranial pressure (ICP). That is headache, 
vomiting, blurring of vision or in severe causes 
decreased levels of conciseness.4 Commonly 
diagnosed on CT brain and MRI where dilation of 
ventricular system.5 
 For a long time, the only treatment for 
Hydrocephalus was ventriculoperitoneal shunting and 
other diversion procedures.6 Endoscopic Third 
Ventriculostomy is a surgical procedure used to treat 
hydrocephalus. In this procedure a stoma is made in 
the floor of third ventricle tuber cinereum using 
an endoscope.6,7 The first choice of non-
communicating hydrocephalus is ETV. Endoscopic 
Third Ventriculostomy is successful in patients with 
less elevated intracranial pressure and patients having 
success score.8-10 
 
MATERIALS AND METHODS 
Study Design 
A prospective observational study was conducted in
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the neurosurgery department of Prime Teaching 
Hospital and Irfan General Hospital Peshawar. Study 
duration was from January 2017 to December 2018. 
 
Inclusion Criteria 
80 patients were considered in this study. 76 were with 
obstructive hydrocephalus and 4 cases of 
communicated hydrocephalus brain tuberculosis. 
 
Exclusion Criteria 
Recurrent cases and those who refused consent due to 
were excluded from the study. 
 
Data Collection 
After taking consent from the patients, data was 
analyzed for all patients who underwent Endoscopic 
Third Ventriculostomy irrespective of the etiological 
type of hydrocephalus. 
 After admitting the patient procedure and 
prognosis based on Endoscopic Third Ventriculostomy 
success score written informed consent is taken. Under 
general anesthesia patient is positioned supine. After 
scrubbing and draping, a single burr hole was made 
over theKocher's point (3 cm lateral to the midline and 
1 cm anterior to the coronal suture). The dura was 
opened in linear fusion. Endoscopetrocar was 
introduced and an endoscope was inserted. Following 
choroid plexus of the lateral ventricles foramen of 
Monro was reached Tuber cinereum and mammillary 
bodies were identified. A stoma was made at tuber 
cinereum with ventriculostomy catheter and kept the 
patient with a ballooned Fogarty catheter. After this, 
an endoscope was removed and the dura was closed 
with silk 4/0 interrupted stitches. Pericranium and 
wound were also closed with interrupted 2/0 Vicryl 
and 2/0 Prolene respectively.1,6,11 
 ETV also has some complications, the most 
common of which are neurovascular injury, 
cerebrospinal fluid leakage, fever and superficial 
wound infection, intra cerebral hematoma, seizures 
altered consciousness and memory disturbance.12,13 
 The data was analyzed for signs/symptoms, 
diagnosis, MRI/CT brain pre-operative findings and 
early post-operative course was studied. These patients 
were followed for 3 months for any improvement in 
signs and symptoms. CT brain was done to see 
improvement in resolutionof hydrocephalus. All 
patients with Third ventricular hydrocephalus due to 
idiopathic aqueductal stenosis, most of the posterior 
fossa tumor, pineal tumor and ICH who were treated 
in this period were included in this study. All 
unwilling patients and those who opted for VP 
shunting rather than ETV were excluded from the 
study. 
 
Data Analysis 
Data was analyzed using SSPS version 22 and 
presented in form tables and charts. 
 
RESULTS 
Gender Distribution 
In this study total 80 patients were included out of 
which 48 were male and 32 were female. 
 
Age Incidence 
Age of patients ranged from 6 months to 60 years. 
Most posterior fossa tumor patients were young having 
age range from 4 to 16 years. Pineal tumor patients 
were from 50 to 65 years. 2 patients with subarachnoid 
hemorrhage had the age of 47 and 60 respectively 
(Table 2). 
 
Clinical Presentation 
All patients were diagnosed with raised ICP due to 
HCP and were considered for ETV surgery. The 
patients presented with common signs and symptoms 
were mostly that of raised ICP. 72 patients (90%) were 
presented with headache and vomiting, 36 patients 
(45%) had papilledema , 4 patients (5%) had lower 
cranial nerve palsy, 2 patients (2.5%) had abducens 
nerve palsy, only 1 patients (1.25%) had confusion, 3 
patients (3.75%) had optic nerve compression and 20 
patients (25%) had ataxia (Table 1). 
 
Table 1:  Clinical Features. 
 
Clinical Features Number & % of Patients 
Headache/Vomiting 72 (90%) 
Papilledema 36 (45%) 
Lower Cranial Nerve palsy 4 (5%) 
Abducent Nerve Palsy 2 (2.50%) 
Confusion 1 (1.20%) 
Optic nerve compression 3 (3.75%) 
Ataxia 20 (25%) 
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Table 2:  Individual success percentage of ETV. 
 
Etiology 
No. of 
Patients 
Male Female Age 
Clinical 
Features 
CT/MRI 
Brain 
Success 
% 
Aqueductal 
stenosis 
 26 15 11 
  1.5 
years 
Raised 
ICP 
10 CT, 19 
MRI 
88 
Posterior fossa 
tumors 
Cerebellar 
astrocytoma 
3 2 1 
25.5 
years 
Raised 
ICP 
3 CT 
87 
Brain Stem 
astrocytoma 
4 3 1 19 years 
Raised 
ICP 
1 CT, 3 MRI 
Ependymoma 
post, fossa 
8 5 3 
14.5 
years 
Raised 
ICP 
2 CT, 6 MRI 
Medulloblastoma 15 9 6   7 years 
Raised 
ICP 
5 CT, 10 
MRI 
CP angle 
Tumors 
 10 7 3 
24.5 
years 
Raised 
ICP 
2 CT, 5 MRI 70 
Pineal Tumors  6 2 4 56 years 
Raised 
ICP 
1 CT , 2 MRI 70 
Hydrocephalus 
TBM 
 4 2 2 
  4.5 
years 
Raised 
ICP 
4 MRI 50 
Intraventricular 
Hemorrhage 
Subarachnoid 
hemorrhage 
2 1 1 55 years 
Raised 
ICP 
3 CT, 4 MRI 70 
Colloid cyst  2 2 0 23 years 
Raised 
ICP 
2 CT 80 
 
 The major tool of investigation as radiological 
investigation in 47% patients was the Brain CT and in 
85% of patients, the MRI brain alone or after CT brain 
was done. Majority of Patients were diagnosed with 
Hydrocephalus (26 patients) due to aqueductal stenosis 
and post fossa tumor (30 patients) while CP angle 
Tumors were 14 patients and 6 patients had pineal 
tumor. 
 All patients were operated on the elective list 
except 10 patients who were operated in an 
emergency. 1.2% (10 patients) had a low level of 
consciousness. All cases had triventricular 
Hydrocephalus except 4 patients who had 
communicating hydrocephalus due to tuberculous 
meningitis. 
 Simple ETV was performed in majority of the 
cases. In all patients with pineal tumor, the biopsy was 
taken along with ETV.However, in one patient with 
pineal tumor biopsy could not be taken due to 
bleeding, while in 2 patients with colloid cyst ETV 
was performed along with septum pellucidotomy. CSF 
for R/E and culture was sent for patient with TBM. In 
pineal tumor patients CSF was taken for tumor 
markers. 
 
Table 3:  Peri-operative Complication. 
 
Peri-operative Complication 
N. of 
Patients 
Bleeding clinically insignificant 6 
Bleeding clinically significant 1 
Insignificant trauma 
to neural structures 
Mammillary body 2 
Fornix 1 
 
 During surgery, total 7 patients had bleeding 2 
patients were of pineal tumor where bleeding started 
after taking biopsy, 2 patients had colloid cyst, 2 with 
aqueductal stenosis and one having an intraventricular 
hemorrhage. In one patient, an extra ventricular drain 
was placed. In event of bleeding we thoroughly 
irrigate with a ringer lactate solution and usually 
Outcome of Endoscopic Third Ventriculostomy: an Experience of 80 Treated Patients 
http//www.pakjns.org         Pak. J. of Neurol. Surg. – Vol. 23, No. 4, Oct. – Dec., 2019         -291- 
bleeding subsides. Post operatively 3 patients had a 
memory problem due to fornix injury in one and 
mammillary body injury in 2 patients (Table 3). 
 Post-operatively, 4 patients had CSF leakage, 
while 5 patients had seizures, 2 patients had superficial 
infection of wound and one patient had an intra-
cerebral hematoma. One patient could not be 
attempted due to excessive bleeding (Table 4). 
 
Table 4:  Post-operative Complications. 
 
Post-operative Complications No. of patients (%) 
Seizures 5 (6%) 
CSF leakage 4 (5%) 
Superficial Infectious Wound 2 (2%) 
Intra Cerebral hematoma 1 (1%) 
 
 All these patients were followed for 3 months. 71 
patients (88%) were symptomatically improved post 
operatively. The patients not improved include 2 
patients of TBM and 4 patients of posterior fossa 
tumor with previous VP shunting. 3 patients were 
those of aqueductal stenosis having age of 3 to 7 
months. Overall, the ETV procedure was successful in 
71 patients (88%) and in 9 patients (11%) it was 
unsuccessful with no improvement. 
 
DISCUSSION 
Mostly preferred surgical procedure for non-
communicating hydrocephalus is ETV. In this 
procedure an endoscope is introduced into the 
ventricular system and the floor of the third ventricle is 
perforated to make a communication with prepontine 
cistern.6,14,15 
 In our study, the ETV was performed for different 
pathologies causing hydrocephalus. Patient having 
aqueductal stenosis ware 32% (26 patients) posterior 
fossa tumor patient were 37% (30 patients) and few 
other conditions mention in table 2. In our study the 
success rate of ETV for aqueductal stenosis is 88% as 
compared to a study done in the neurosurgery 
department, university of MAINZ, Germany having 
success rate of 81%.6 The slight difference is due to 
patient population with our study, we attempted ETV 
in patients with aqueductal stenosis, posterior fossa, 
Pineal tumor, etc. while in their study, the spectrum of 
disease is wide including cerebellum infarction, vein
of galen malformation, metastasis and lymphomas etc. 
 In our patients, the success rate of ETV in pineal 
tumor patients was 70% as compared to the success 
rate of 100% in a study done at the university hospital 
of Toulouse.16 The difference in result is because our 
patients were less in number as compared to their 
study.In all these patients ETV was followed by 
biopsy of the tumor during which two patients had 
bleeding. In one of these patients extra ventricular 
drain was placed. These factors have affected the 
outcomes in these patients. 
 The success rate of posterior fossa tumor in our 
study was 87% as compared to study done at The 
Children Hospital, Pittsburgh which was 84%, which 
is comparable.17 In the department of Neurosurgery, 
University of Utah, School of Medicine, 3% (1 
patient) have CSF leakage as compared to our study 
having patients with CSF leakage 5% (4 patients) 
which is acceptable. 
 The incidence of infection in the above study is 
3% (1 patient) while in our study it is 2% (2 patients) 
which is comparable. The overall complications in the 
above study are 14% as compared to our study 15%. In 
our study, one patient could not be attempted due to 
excessive bleeding, while in the comparable study, 
there is 1 unsuccessful ETV procedure.18 
 
CONCLUSION 
ETV is less invasive and effective treatment for non-
communicating hydrocephalus.The success rate of 
ETV is highest in aqueductal stenosis and posterior 
fossa tumors while lowest in Hydrocephalus TBM. 
The overall success rate of ETV is 74%. The most 
common post-operative complications are seizures and 
CSF leakage. Based on these findings, it is 
recommended that ETV should be attempted as first 
line treatment for patients with triventricular 
hydrocephalus due to various pathologies. 
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